|

Selumetinib Oral Capsule Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Koselugo

Pipeline

Phase 1: 1

Top Sponsors

  • Girish Dhall, MD1

Indications

  • Plexiform Neurofibroma1
  • Neurofibromatosis 11
  • Cancer1

Birmingham, Alabama1 trial

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Childrens of Alabama

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.